Doxorubicin Nanoparticles are an injectable drug made up of microscopic polymer based spheres containing the drug doxorubicin. Doxorubicin, a chemotherapy drug used to treat many types of cancer, slows or stops the growth of cancer cells by blocking an enzyme called topoisomerase 2.2 Studies on doxorubicin nanoparticles on people with advance HCC have suggested it may extend lifespan. If doxorubicin nanoparticles is licenced in the UK, it could provide a new treatment option for patients with advance HCC when other treatment options have failed, which may extend patient survival time.
Intravenous Doxorubicin Nanoparticles for Advanced Hepatocellular Carcinoma
Interventions: Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride)
Indications: Hepatocellular carcinoma (HCC)
Therapeutic Areas: Gastrointestinal Cancer